Latest filing published 24 Jan 2023 for Pear Therapeutics, Inc., €13k.
No signal scores available.
Julia Strandberg is a declared insider of Pear Therapeutics, Inc., with filings sourced from SEC (Form 4). In total, 2 filings cover trades dated from 14 January 2023 to 20 January 2023.
No open-market purchase appears, only 1 sale worth €13k. Outside the open market, there are 1 option exercise.
The latest filing, published on 24 January 2023, reports an open-market sale of €13k in Pear Therapeutics, Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations